Dual expression vector system for antibody expression in bacterial and mammalian cells

Details for Australian Patent Application No. 2004204462 (hide)

Owner Macrogenics, Inc.

Inventors Huang, Ling; Johnson, Leslie Sydnor

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004204462

PCT Pub. Number WO2004/063343

Priority 60/439,492 09.01.03 US

Filing date 8 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 8 March 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/063343 Priority application(s): WO2004/063343

8 March 2012 Application Accepted

  Published as AU-B-2004204462

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204463-Catalytic domains of beta(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use

2004204456-Cellular delivery and activation polypeptide-nucleic acid complexes